Literature DB >> 10442182

Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer--too good to be true?

M M Borner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10442182     DOI： 10.1023/a:1008353227103

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  20 in total

Review 1.  The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2016-12

2.  Can the National Health Service Cancer Plan timeline be applied to colorectal hepatic metastases?

Authors:  Claire Jones; Stephen A Badger; Jane McClements; Lloyd McKie; Tom Diamond; Mark A Taylor
Journal:  Ann R Coll Surg Engl       Date:  2010-03       Impact factor: 1.891

3.  The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.

Authors:  Bart A W Jacobs; Nikol Snoeren; Morsal Samim; Hilde Rosing; Niels de Vries; Maarten J Deenen; Jos H Beijnen; Jan H M Schellens; Miriam Koopman; Richard van Hillegersberg
Journal:  Eur J Clin Pharmacol       Date:  2018-02-11       Impact factor: 2.953

4.  Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons.

Authors:  Waleed M Mohammad; Guillaume Martel; Richard Mimeault; Robert J Fairfull-Smith; Rebecca C Auer; Fady K Balaa
Journal:  HPB (Oxford)       Date:  2012-02-09       Impact factor: 3.647

Review 5.  Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review.

Authors:  Kuniya Tanaka; Yasushi Ichikawa; Itaru Endo
Journal:  Int J Clin Oncol       Date:  2011-07-26       Impact factor: 3.402

6.  Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Authors:  René Adam; Valérie Delvart; Gérard Pascal; Adrian Valeanu; Denis Castaing; Daniel Azoulay; Sylvie Giacchetti; Bernard Paule; Francis Kunstlinger; Odile Ghémard; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

7.  A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

Authors:  Nikol Snoeren; Emile E Voest; Andre M Bergman; Otilia Dalesio; Henk M Verheul; Rob A E M Tollenaar; Joost R M van der Sijp; Sander B Schouten; Inne H M Borel Rinkes; R van Hillegersberg
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

Review 8.  Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer.

Authors:  Muhammad Wasif Saif
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

Review 9.  Metastatic colorectal cancer-past, progress and future.

Authors:  Kathryn Field; Lara Lipton
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

10.  Serum human epididymis protein 4 levels in colorectal cancer patients.

Authors:  Yasemi N Kemal; Guzi N Demirag; Abdulkeri M Bedir; Leman Tomak; Murat Derebey; Di Lek Erdem; Ufuk Gör; Idris Yücel
Journal:  Mol Clin Oncol       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.